SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001633070-22-000014
Filing Date
2022-05-05
Accepted
2022-05-05 07:41:15
Documents
14
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axla-20220505.htm   iXBRL 8-K 40944
2 EX-99.1 ex9912022q1.htm EX-99.1 53583
6 GRAPHIC imagea.jpg GRAPHIC 14688
  Complete submission text file 0001633070-22-000014.txt   263553

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axla-20220505.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axla-20220505_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axla-20220505_pre.xml EX-101.PRE 13045
8 EXTRACTED XBRL INSTANCE DOCUMENT axla-20220505_htm.xml XML 11679
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38901 | Film No.: 22894116
SIC: 2836 Biological Products, (No Diagnostic Substances)